Centamin Egypt Limited
12 December 2006
Centamin Egypt Limited
('Centamin' or 'the Company')
Director's Shareholding and Issue of Equity
The Company announces that, following the exercise of options issued under the
Employee Share Option Plan 2002, 115,000 ordinary shares have been issued and
allotted today at an exercise price of A$0.3549 per share to Dr Thomas Gee
Elder, a director of the Company.
Following this exercise, Dr Elder's holding in the Company is 250,000 fully paid
ordinary shares, representing 0.04 percent of the issued share capital of the
Company, and 500,000 unlisted options.
Application has been made for the new ordinary shares to be admitted to trading
on AIM. The new ordinary shares will rank pari passu with the existing ordinary
shares in the Company and trading of these shares on AIM is expected to commence
on 19 December 2006.
The total number of Ordinary Shares on issue following this issue is
579,415,369.
12 December 2006
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.